Global Diabetes Pen Market Size, Share, Future Trends, Countless Growth Opportun

Posted by Nita on November 16th, 2019

Increasing Cases of Obesity Projected to Drive the Global Diabetes Pen Market in the Coming Years

The Global Diabetes Pen Market Is Expected To Grow At A Notable CAGR Of 8.45% During The Forecast Period Between 2017 And 2023. Moreover, Market Research Future (MRFR) Forecasts That The Global Market Will Garner A Valuation Of USD 9.85 Billion By The End Of The Forecast Period.

 

Diabetes is a highly concerning and prevalent chronic disease across the globe. The prevalence and the subsequent impact upon the affected patients have made leading researchers, developers, scientists, and innovators to come up with a new and innovative product to tackle the same.

Insulin is a hormone that is produced by the help of pancreas. However, during diabetes, the pancreas fails to produce the requisite insulin for the body. In order to inject insulin, a diabetes pen is required for the treatment of diabetes. The product consists of an insulin cartridge, one which is either integrated or bought separately, and a dial that is used to measure the dosage level. This is used with disposable pen needles that helps deliver the dosage. The high intake of sugar and carbs, increasing cases of obesity, and the evolving consumer lifestyle are some of the major factors spreading the prevalence of this disease.

Competitive Landscape

The global diabetes pen market comprises numerous players, including Becton, Dickinson and Company (U.S.), AstraZeneca (U.K), Teruma Medical Corporation (Japan), F. Hoffman La Roche AG (Switzerland), Greinier Bio One International GmBH (U.S.), Bayer Cropscience Ltd. (Germany), and HTL STREFA SA (Poland). The players are innovating with new products and consistently conducting research and development activities to edge past the competition and strengthen their global reach.

Feb 18th, 2019, Glooko, a diabetic’s data management organization, announced that its latest Novo Nordisk connected insulin pens will be connected to the diasend platform. The soon-to-be launched devices will be Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus.

Global Diabetes Pen Market Information: By Product (Insulin Pens And Insulin Pen Needle), By Usage (Reusable Pens And Disposable Pens), And By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Sales, And Diabetes Clinics) - Forecast Till 2023  : https://www.marketresearchfuture.com/reports/global-diabetes-pen-market-564

 

Like it? Share it!


Nita

About the Author

Nita
Joined: November 14th, 2019
Articles Posted: 620

More by this author